<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01059929</url>
  </required_header>
  <id_info>
    <org_study_id>16865B</org_study_id>
    <nct_id>NCT01059929</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU)</brief_title>
  <official_title>A Double-blinded Randomized Controlled Trial of Dexmedetomidine Versus Propofol for Sedation in Mechanically Ventilated Medical Intensive Care Unit Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospira, now a wholly owned subsidiary of Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial to compare propofol to dexmedetomidine for prolonged
      sedation (&gt; 24 hours) in critically ill patients who require mechanical ventilation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mechanically ventilated critically ill patients are routinely given sedative and analgesic
      medications to relieve pain and anxiety associated with intubation, mechanical ventilation,
      and critical care in general. While integral in minimizing discomfort, these medications may
      increase mechanical ventilation time, the duration of intensive care unit (ICU) stay, ICU
      complications (e.g. delirium, ventilator associated pneumonia, venous thromboembolism), the
      morbidity associated with critical illness, and patient mortality. This study compares two
      sedative medications that have been used in patients who require a mechanical ventilator.
      Enrolled patients will be randomly assigned to receive propofol or dexmedetomidine for
      sedation while they require ventilatory support. All patients will also receive the pain
      medication fentanyl as needed.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2009</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Delirium</measure>
    <time_frame>Daily</time_frame>
    <description>CAM-ICU assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Drug Efficacy</measure>
    <time_frame>Daily</time_frame>
    <description>Richmond Agitation Sedation Scale (RASS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobility milestones</measure>
    <time_frame>Daily</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days on ventilator</measure>
    <time_frame>28 days from enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days in ICU</measure>
    <time_frame>28 days from enollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>28 days from enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU complications</measure>
    <time_frame>Duration of ICU admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fentanyl requirement</measure>
    <time_frame>During infusion of study medication</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Midazolam requirement</measure>
    <time_frame>During infusion of study medication</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days in Hospital</measure>
    <time_frame>28 days from enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activities of daily living</measure>
    <time_frame>Up to 1 year from enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse medication effects</measure>
    <time_frame>During infusion of study medication</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Mechanical Ventilation</condition>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will receive continuous dexmedetomidine infusion (0.2 - 1.5 mcg/kg/hour) titrated to the target Richmond Agitation Sedation Scale for the duration of mechanical ventilation or 7 days on study, whichever is first.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will receive propofol (5 - 50 mcg/kg/min) for sedation, titrated to the target Richmond Agitation Sedation Scale for the duration of mechanical ventilation or 7 days on study, whichever is first.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>continuous IV infusion 0.2 - 1.5 ucg/kg/hour titrated to target RASS</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>continuous IV infusion (5 - 50 ucg/kg/min) titrated to target RASS</description>
    <arm_group_label>Propofol</arm_group_label>
    <other_name>Diprivan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>25 - 200 mcg IV every hour (as multiple IV pushes) as needed titrated to Non-Verbal Pain Scale</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>0.01 - 0.1 mg/kg IV push every 10 minutes as needed for agitation (RASS&gt;+2)</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_label>Propofol</arm_group_label>
    <other_name>Versed</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical and Occupational Therapy</intervention_name>
    <description>Daily therapy sessions targeting range of motion, strength, and mobility</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 years old

          -  mechanically ventilated through endotracheal tube

          -  anticipated need for ventilation &gt; 48 hours

          -  requiring sedative/analgesic medication

        Exclusion Criteria:

          -  on mechanical ventilator &gt; 96 hours

          -  primary neurologic disease

          -  post cardiac arrest

          -  do not speak English (assessment only English language validated)

          -  pregnancy or lactation

          -  active myocardial ischemia

          -  second or third degree heart block

          -  pancreatitis

          -  elevated serum triglycerides (&gt; 400 mg/dL)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John P Kress, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2009</study_first_submitted>
  <study_first_submitted_qc>January 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2010</study_first_posted>
  <last_update_submitted>December 2, 2014</last_update_submitted>
  <last_update_submitted_qc>December 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypnotics and Sedatives</keyword>
  <keyword>Respiration, Artificial</keyword>
  <keyword>Ventilators, Mechanical</keyword>
  <keyword>Critical care</keyword>
  <keyword>Intensive care</keyword>
  <keyword>Physical therapy</keyword>
  <keyword>Occupational therapy</keyword>
  <keyword>Sedative medications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>November 1, 2016</submitted>
    <returned>December 28, 2016</returned>
    <submitted>June 30, 2017</submitted>
    <returned>July 28, 2017</returned>
    <submitted>September 11, 2017</submitted>
    <returned>October 11, 2017</returned>
    <submitted>October 11, 2017</submitted>
    <returned>November 9, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

